Fig. 2From: Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patientsSignificant positive correlation between the baseline ALT and posttreatment I-FABP level in HCV/HIV co-infected group (r = 0.340, P-value = 0.016)Back to article page